Acid suppression by famotidine 20 mg twice daily or 40 mg twice daily in preventing relapse of endoscopic recurrence of erosive esophagitis

Authors: Simon T.J.¹; Roberts W.G.; Berlin R.G.; Hayden L.J.; Berman R.S.; Reagan J.E.

Source: Clinical Therapeutics, Volume 17, Number 6, November 1995 , pp. 1147-1156(10)

Publisher: Elsevier

Language: English

Document Type: Research article

DOI: 10.1016/0149-2918(95)80093-X

Affiliations: 1: Merck Research Laboratories, West Point, Pennsylvania, U.S.A.

Links for this article

http://www.ingentaconnect.com/els/01492918/1995/00000017/00000006/art80093
http://openurl.ingenta.com/content?genre=article&issn=0149-2918&volume=17&issue=6&spage=1147&epage=1156
http://dx.doi.org/10.1016/0149-2918(95)80093-X